Bismaleimide modified product and method for producing the same

    公开(公告)号:US11104643B2

    公开(公告)日:2021-08-31

    申请号:US16930397

    申请日:2020-07-16

    申请人: UNITIKA LTD.

    IPC分类号: C07D207/448

    摘要: An object of the present invention is to provide a bismaleimide (D-BMI) modified product in which an amino group of dimer diamine (DDA) is maleimidized, which has the good heat resistance, and has the sufficiently enhanced processability, and a method for producing the same. There are provided: A bismaleimide (D-BMI) modified product in which an amino group of dimer diamine is maleimidized, the bismaleimide modified product having the following characteristics: 1) An acid value of the D-BMI modified product is 2 mg-KOH/g or less. 2) In 1H-NMR, when quantitative comparison is performed using an integrated value (A) of a peak corresponding to a proton of a methylene group directly bound to a nitrogen atom of a maleimide group and an integrated value (B) of a peak corresponding to a vinyl proton of a maleimide group, A/B is 1.25 or more and 2.00 or less. A method for producing D-BMI, the method including the following steps: 1) A step of preparing a crude D-BMI solution having an acid value of more than 2 mg-KOH/g. 2) A step of lowering an acid value of D-BMI to 2 mg-KOH/g or less by reacting an acid component in the solution with a carbodiimide compound. 3) A step of reacting the solution without a catalyst at 110 to 200° C. in a solvent.

    JAK3 SELECTIVE INHIBITOR
    3.
    发明申请

    公开(公告)号:US20210214344A1

    公开(公告)日:2021-07-15

    申请号:US17059211

    申请日:2019-05-30

    摘要: The present invention relates to a compound of Formula (I)/(II) or pharmaceutically acceptable salts thereof. In Formula (I), Rh, Rg, Rf, m, Re, Rd, Ra, Rb, and Rc are as defined in the description. The present invention further relates to a pharmaceutical composition comprising the compound of Formula (I)/(II) or pharmaceutically acceptable salts thereof, and use of the compound of Formula (I)/(II) or the pharmaceutical composition in the manufacture of a medicament for treating inflammations such as rheumatoid arthritis.

    METHOD FOR PRODUCING MALEIMIDE COMPOUND, COMPOUND AND SOLID RESIN

    公开(公告)号:US20200308112A1

    公开(公告)日:2020-10-01

    申请号:US16824082

    申请日:2020-03-19

    发明人: Kazuaki Ebisawa

    摘要: A method for producing a maleimide compound having a group represented by the formula (a1), the method including condensing a primary amino group in a raw material compound having the primary amino group and dicarboxylic anhydride represented by the formula (a2) to generate a group represented by the formula (a3); and heating a compound having the group represented by the formula (a3), and converting the group represented by the formula (a3) into the group represented by the formula (a1).

    BISMALEIMIDE MODIFIED PRODUCT AND METHOD FOR PRODUCING THE SAME

    公开(公告)号:US20180362463A1

    公开(公告)日:2018-12-20

    申请号:US16011077

    申请日:2018-06-18

    申请人: UNITIKA LTD.

    IPC分类号: C07D207/448

    CPC分类号: C07D207/448

    摘要: An object of the present invention is to provide a bismaleimide (D-BMI) modified product in which an amino group of dimer diamine (DDA) is maleimidized, which has the good heat resistance, and has the sufficiently enhanced processability, and a method for producing the same. There are provided: A bismaleimide (D-BMI) modified product in which an amino group of dimer diamine is maleimidized, the bismaleimide modified product having the following characteristics: 1) An acid value of the D-BMI modified product is 2 mg-KOH/g or less. 2) In 1H-NMR, when quantitative comparison is performed using an integrated value (A) of a peak corresponding to a proton of a methylene group directly bound to a nitrogen atom of a maleimide group and an integrated value (B) of a peak corresponding to a vinyl proton of a maleimide group, A/B is 1.25 or more and 2.00 or less. A method for producing D-BMI, the method including the following steps: 1) A step of preparing a crude D-BMI solution having an acid value of more than 2 mg-KOH/g. 2) A step of lowering an acid value of D-BMI to 2 mg-KOH/g or less by reacting an acid component in the solution with a carbodiimide compound. 3) A step of reacting the solution without a catalyst at 110 to 200° C. in a solvent.

    Method for Preparing N-Substituted Maleimides
    10.
    发明申请
    Method for Preparing N-Substituted Maleimides 有权
    N-取代的马来酰亚胺的制备方法

    公开(公告)号:US20110124882A1

    公开(公告)日:2011-05-26

    申请号:US12999420

    申请日:2009-06-24

    IPC分类号: C07D207/448

    CPC分类号: C07D207/448

    摘要: The present invention relates to a method of preparing N-substituted maleimide in high purity and high yield, wherein, unlike a conventional method of preparing N-substituted maleimide after preparing N-substituted maleamic acid, an organic solvent, an acid catalyst, a dehydration co-catalyst and a stabilizer are added into a reactor without separately preparing N-substituted maleamic acid, and then a primary amine is added into the reactor to form an amine salt, maleic anhydride is added into the reactor, and the resulting mixture is subjected to a dehydration-cyclization reaction, wherein water produced during the reaction is azeotropically distilled with the organic solvent so as to effectively suppress formation of a maleimide polymer. Particularly, the invention simplifies the process, has high yield, minimizes side reactions, eliminates the introduction of expensive raw materials and the complicated treatment of the reaction solution and significantly shortens the time over which the raw materials and maleic anhydride are added.

    摘要翻译: 本发明涉及以高纯度和高收率制备N-取代马来酰亚胺的方法,其中与制备N-取代马来酰胺酸,有机溶剂,酸催化剂,脱水剂的常规制备N-取代马来酰亚胺的方法不同 助催化剂和稳定剂加入到反应器中,而无需单独制备N-取代的马来酰胺酸,然后将伯胺加入到反应器中以形成胺盐,将马来酸酐加入到反应器中,并将所得混合物 进行脱水 - 环化反应,其中在反应期间产生的水与有机溶剂共沸蒸馏,以有效抑制马来酰亚胺聚合物的形成。 特别地,本发明简化了方法,具有高产率,最小化副反应,消除了昂贵原料的引入和复杂的反应溶液处理,并显着缩短了添加原料和马来酸酐的时间。